101 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
7 May 24
Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
4:02pm
is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Gossamer Bio Statement of Operations
Condensed
8-K
EX-99.1
GOSS
Gossamer Bio Inc
6 May 24
Entry into a Material Definitive Agreement
7:31am
in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
For Investors
8-K
EX-99.1
GOSS
Gossamer Bio Inc
5 Mar 24
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:31am
harbor provisions of the Private Securities Litigation Reform Act of 1995.
GOSSAMER BIO, INC.
CONDENSED CONSOLIDATED FINANCIAL STATEMENT DATA
8-K
EX-10.1
6ktlpd
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
8-K
EX-99.1
69503j50jnz5uzkq 5h5
9 Nov 23
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
7:31am
424B3
t7rhvi
28 Aug 23
Prospectus supplement
4:29pm
S-3
bgo6kifb2i
18 Aug 23
Shelf registration
8:41am
S-3ASR
jah7rx1kcs3v2sp8ec
17 Aug 23
Automatic shelf registration
4:01pm
8-K
EX-99.1
183zm9
8 Aug 23
Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update
4:01pm
8-K
bfo nps6jm1g
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
EX-10.1
6f7pd3m0 5kmlfw
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
EX-99.1
smptxf51s2fiaeolk9e
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
EX-99.1
ci4 4elkv
20 Jul 23
Interim TORREY OLE Update and PROSERA Phase 3 Design July 2023
7:50am
8-K
EX-99.1
fsqlb4 tu47d8
9 May 23
Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update
4:03pm